Infographic: 33 States and Puerto Rico Have Enacted Biosimilar Substitution Laws

As of July, 2017, 33 US states and Puetro Rico have enacted laws concerning biosimilar substitution. 
The Center for Biosimilars Staff
July 02, 2017
As of July, 2017, 33 US states and Puetro Rico have enacted laws concerning biosimilar substitution. View the infographic here, or read more about the variation in state legislation. 

x-button

Click here to view Biosimilars CME Activities

Click here to view Biosimilars PTCE Activities

Health economics experts. Managed care professionals. Key clinical specialists. This is where the worlds of clinical, regulatory, and economical outcomes for specialized pharmaceutical biotechnology meet: The Center for Biosimilars is your online resource for emerging technologies, with a focus on improving critical thinking in the field to impact patient outcomes. We’ll discuss the current landscape for advanced health care management—reviewing emerging treatment paradigms, approaches, and considerations—all by authoritative industry voices.

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright © 2006-2019 Intellisphere, LLC. All Rights Reserved.